In 2026, Shanghai is a global hub for cellular immunotherapy, and the best CAR-T therapy hospitals in Shanghai are including Shanghai Ruijin Hospital, Shanghai GoBroad Cancer Hospital, and Jiahui International Hospital, etc.. These facilities provide international patients with cutting-edge treatments like Fucaso and Relma-cel, often at a car t cell therapy cost in china that is 70% lower than US benchmarks.
1. Shanghai Ruijin Hospital (Jiao Tong University)
Ruijin Hospital is arguably the most prestigious hematology center in Asia. In early 2026, Ruijin reported a 94.4% overall response rate for its novel GPRC5D-targeted CAR-T trials, proving its status as a pioneer in relapsed/refractory Multiple Myeloma.
- Best For: Complex blood cancers and patients who have failed prior BCMA therapies.
- Foreigner Support: The hospital’s International Medical Center (IMC) offers bilingual staff and streamlined registration for expats.
- Official Site: Ruijin Hospital
2. Shanghai GoBroad Cancer Hospital
GoBroad is a private, research-heavy powerhouse located in the Shanghai Pilot Free Trade Zone. It is famous for its comprehensive target portfolio, including dual-target CAR-T (CD19-22) which significantly reduces relapse rates.
- Best For: Precision medicine and “sequential” CAR-T therapies.
- Foreigner Support: They provide full S2 Medical Visa invitation letters and dedicated English-speaking care coordinators.
- Official Site: GoBroad Healthcare Group
3. Shanghai Jiahui International Hospital
If you prioritize a Western-style healthcare experience, Jiahui is the top choice. As a strategic partner of Massachusetts General Hospital, Jiahui combines US clinical standards with China’s rapid cell manufacturing.
- Best For: International patients seeking JCI-accredited care and seamless insurance direct billing.
- Success Story: Recently successfully treated a 78-year-old New Zealand doctor with CAR-T, achieving MRD negativity in just two weeks.
- Official Site: Jiahui Health
4. Fudan University Shanghai Cancer Center (FUSCC)
FUSCC is at the forefront of the “next frontier”: CAR-T for solid tumors. In 2026, they are actively enrolling patients for CD70-targeted CAR-NKT trials and GPC3-targeting for liver cancer.
- Best For: Solid tumor clinical trials (Gastric, Pancreatic, and Liver cancers).
- Foreigner Support: Best suited for patients working with an independent medical escort due to the high volume of local patients.
- Official Site: FUSCC
5. Zhongshan Hospital (Fudan University)
Zhongshan is renowned for its multidisciplinary approach. It is currently leading innovative studies into hypoxia-inducible CAR-T cells for Stage IV gastric cancer, a technology designed to survive the harsh environment of solid tumors.
- Best For: Advanced gastric cancer and patients requiring integrated organ-function support.
- Official Site: Zhongshan Hospital
Comparing the Cost in Shanghai
While the medical expertise in Shanghai is world-class, the car t cell therapy cost in china remains the primary reason for medical tours in Shanghai.
| Hospital | Est. Total Cost (USD) | Patient Experience |
| Ruijin Hospital | $60k – $90k | High-Authority Public |
| GoBroad Shanghai | $80k – $120k | Specialized Research |
| Jiahui International | $100k – $150k | Premium Western-Style |
How to Apply for Treatment
To begin your journey, you must submit a recent PET-CT scan and pathology report to the hospital’s International Department. If you are eligible, the hospital will issue the Medical Invitation Letter required for your 2026 entry.